Our Team

Mr. Giroux is a 20-year medical industry veteran with involvement in more than 35 human-use clinical trials in addition to pre-clinical work with rodents, larger mammals, and non-human primates (NHPs). He has worked in the development of new technology in medical devices, medical services, and high-end manufacturing. Utilizing his skills in physics and fluid dynamics, he developed the functional specifications behind all of the technology being used in Kurve’s nose-to-brain drug delivery. The intellectual property owned by Kurve has Marc as the lead or sole inventor. In his capacity at Kurve, he has consulted extensively with companies developing new therapies for neurodegenerative diseases with regard to formulation and device compatibility. As co- or lead author, he has published trade journals and peer-reviewed articles. Before taking on the CEO role, Mr. Giroux was a C-level business development executive and Subject Matter Expert on building executive teams.